Invesco Bloomberg Analyst Rating Imp ETF(UPGD.US)

Last Updated 19:00:00 ET
longbridge loading
Company Encyclopedia
View More
name
Invesco Bloomberg Analyst Rating Imp ETF
UPGD.US
News
View More

BMS reports positive results in Phase III SCOUT-HCM trial for oHCM

Bristol Myers Squibb (BMS) has reported positive results from the Phase III SCOUT-HCM trial for Camzyos (mavacamten) in treating symptomatic obstructive hypertrophic cardiomyopathy (oHCM) in adolescents aged 12 to under 18. The trial met its primary endpoint, showing significant reduction in Valsalva left ventricular outflow tract (LVOT) gradient at week 28 compared to placebo. Safety data remained consistent with adult profiles, and BMS plans to present comprehensive results at a medical congress. The study continues with active treatment and long-term extension phases.

WorldPharmaceuticals·
US
BMY
-2.40%
WorldPharmaceuticals·
US
BMY
-2.40%

US Stock Market Close | S&P 500 Index Hits New High, Auto Retailers Lead the Way

U.S. stocks closed with the overall market continuing its strong performance, with all three major indices advancing together. The Dow Jones Industrial Average and the S&P 500 Index reached new historical highs, with the automotive retailers and engineering machinery sectors performing prominently, as AutoZone and Caterpillar rose by 2.98% and 1.97%, respectively. The Federal Reserve kept interest rates unchanged, and macroeconomic indicators show strong economic resilience, but caution is needed regarding potential volatility risks in the future

Market Heartbeat·
US
CAT
-0.04%
US
CMI
+0.71%
Market Heartbeat·
US
CAT
-0.04%
US
CMI
+0.71%

Does Cognizant’s Upgraded EPS Outlook and AI Push Reshape The Bull Case For Cognizant (CTSH)?

Cognizant Technology Solutions has raised its fiscal Q4 2025 adjusted EPS guidance to US$5.22–US$5.26 and increased its annual revenue forecast to US$21.05 billion, driven by strong performance and AI-focused growth plans. The upcoming Q4 results will be crucial in assessing whether AI-driven growth can counter margin pressures and competition. Investors are encouraged to consider various fair value estimates, which range from US$66 to US$125 per share, reflecting differing views on Cognizant's future prospects. The narrative emphasizes the importance of AI in securing large digital transformation deals.

Simplywall·
US
CTSH
-0.09%
Simplywall·
US
CTSH
-0.09%

Caterpillar Confirms Structural Nesting In The S&P 500 With Targets At 10,000

Caterpillar (CAT) confirms its structural nesting in the S&P 500, indicating a bullish outlook with targets between $800-$900. The stock's price behavior suggests stability and leadership, supporting the notion that the S&P 500 is forming a durable base for a long-term upward move. Analysts project a minimum target of 10,000 for the S&P 500, with potential extensions to 12,000, despite skepticism from traders. The correlation between Caterpillar and the S&P 500 reinforces the expectation of a significant market move soon.

Talkmarkets·
US
CAT
-0.04%
Talkmarkets·
US
CAT
-0.04%

Caterpillar CEO Joseph Creed To Become Board Chairman

Caterpillar Inc. announced that CEO Joseph Creed will become chairman of the board on April 1, succeeding James Umpleby III, who will retire after 45 years with the company. Debra Reed-Klages will remain as lead independent director. Creed has been with Caterpillar since 1997 and became CEO in 2025. The company's stock closed at $623.09, up 1.13%, and traded at $624.99 in after-market hours.

rttnews·
US
CAT
-0.04%
rttnews·
US
CAT
-0.04%
© 2026 Longbridge｜Disclaimer